RecallDepth
Class II Ongoing

Rizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Product of India, NDC 68462-465-99

This recall is currently active, issued June 12, 2024. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
May 10, 2024
Posted
June 12, 2024
Recall Number
D-0532-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,480 cartons
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Distribution

US Nationwide.

Lot / Code Info

Lot#: 19233788; Exp. 9/2025 Lot#: 19224445; Exp. 9/2024

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls